ALKS 27 Uses, Dosage, Side Effects and more
ALKS 27 is an inhaled formulation of trospium chloride for the treatment of chronic obstructive pulmonary disease (COPD). Study showed that ALKS 27 was well-tolerated over a wide dose range, with no dose-limited effects observed.
| Attribute | Details |
|---|---|
| Trade Name | ALKS 27 |
| Generic | ALKS 27 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in chronic obstructive pulmonary disease (COPD).
How ALKS 27 works
ALKS 27 is a muscarinic receptor antagonist that relaxes smooth muscle tissue and has the potential to improve airflow in patients with chronic obstructive pulmonary disease (COPD).
